Atonco today announces that Sylvain Fanier, MSc. EMBA, will succeed Professor Jean-François Chatal as Chairman effective March 16, 2020.
Sylvain Fanier has dedicated his career to overseeing and driving the development of several global medical innovations in the healthcare sector. He brings to the company strategic leadership and a global perspective on business and financing, acquired over 30 years at major corporations such as Johnson & Johnson and CR Bard, as well as in medical startups. Specializing in disruptive medical innovation, he has supported the success of innovative companies such as Lemerpax, Cardioinsight, Sonoscanner, Soundbite Medical Solutions, Surgivisio, and Med-Innov through his consulting firm, Novariver.
He holds a bachelor’s degree in biochemistry and a master’s degree in biology with a specialization in physiology from the Université Paul Sabatier in Toulouse. He also holds an EMBA from ESSEC, Paris, France.
Sylvain serves on the board of directors of Soundbite Medical Solutions Inc. (Montreal, Canada) and Ecential Robotics SAS (Grenoble, France).
I am delighted that Sylvain is taking on the role of Chairman. I am certain he will play a decisive role in the development and success of Atonco. I am also pleased that Jean-François Chatal will remain engaged in our developments as co-founder and Chief Medical Officer.
Jean-Pierre Cabocel, Chairman of the Board of Directors
It is an honor to be appointed Chairman of Atonco. With the support of the management team and our talented and experienced advisors, we will optimize our development, strengthen our organization and partnerships to ensure Atonco’s continued growth.
Sylvain Fanier
About ATONCO
ATONCO is a French private company developing molecularly targeted radiopharmaceutical products for oncological applications. Originating from the world-class nuclear medicine centre in Nantes, ATONCO and its partners are committed to the clinical use of alpha-emitting radionuclides, particularly astatine-211 (²¹¹At).
For more information, visit www.atonco-pharma.com